Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

被引：181

作者：

Gerhauser, Clarissa ^{[1
]}

Favero, Francesco ^{[2
,3
]}

Risch, Thomas ^{[4
]}

Simon, Ronald ^{[5
]}

Feuerbach, Lars ^{[6
]}

Assenov, Yassen ^{[1
]}

Heckmann, Doreen ^{[7
,8
]}

Sidiropoulos, Nikos ^{[2
,3
]}

Waszak, Sebastian M. ^{[9
]}

Huebschmann, Daniel ^{[10
,11
,12
]}

Urbanucci, Alfonso ^{[13
,14
,15
]}

Girma, Etsehiwot G. ^{[2
,3
]}

Kuryshev, Vladimir ^{[7
,8
]}

Klimczak, Leszek J. ^{[16
]}

Saini, Natalie ^{[17
]}

Stuetz, Adrian M. ^{[9
]}

Weichenhan, Dieter ^{[1
]}

Boettcher, Lisa-Marie ^{[5
]}

Toth, Reka ^{[1
]}

Hendriksen, Josephine D. ^{[2
,3
]}

Koop, Christina ^{[5
]}

Lutsik, Pavlo ^{[1
]}

Matzk, Soeren ^{[4
]}

Warnatz, Hans-Joerg ^{[4
]}

Amstislayskiy, Vyacheslav ^{[4
]}

Feuerstein, Clarissa ^{[1
,18
]}

Raeder, Benjamin ^{[9
]}

Bogatyrova, Olga ^{[1
]}

Schmitz, Eva-Maria ^{[19
]}

Hube-Magg, Claudia ^{[5
]}

Kluth, Martina ^{[5
]}

Huland, Hartwig ^{[20
]}

Graefen, Markus ^{[20
]}

Lawerenz, Chris ^{[10
]}

Henry, Gervaise H. ^{[21
]}

Yamaguchi, Takafumi N. ^{[22
]}

Malewska, Alicia ^{[21
]}

Meiners, Jan ^{[5
]}

Schilling, Daniela ^{[7
,23
,24
]}

Reisinger, Eva ^{[10
]}

Eils, Roland ^{[10
,11
]}

Schlesner, Matthias ^{[10
,25
]}

Strand, Douglas W. ^{[21
]}

Bristow, Robert G. ^{[26
]}

Boutros, Paul C. ^{[27
,28
]}

von Kalle, Christof ^{[8
,29
]}

Gordenin, Dmitry ^{[17
]}

Sueltmann, Holger ^{[7
,8
]}

Brors, Benedikt ^{[6
,8
,30
]}

Sauter, Guido ^{[5
]}

机构：

[1] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany

[2] Rigshosp, Finsen Lab, DK-2200 Copenhagen, Denmark

[3] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark

[4] Max Planck Inst Mol Genet, Otto Warburg Lab Gene Regulat & Syst Biol Canc, Ihnestr 63-73, D-14195 Berlin, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany

[6] German Canc Res Ctr, Div Appl Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany

[7] German Canc Res Ctr, Div Canc Genome Res, D-69120 Heidelberg, Germany

[8] German Canc Consortium DKTK, D-69120 Heidelberg, Germany

[9] European Mol Biol Lab, Genome Biol Unit, D-69120 Heidelberg, Germany

[10] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany

[11] Heidelberg Univ, Inst Pharm & Mol Biotechnol & Bioquant, Dept Bioinformat & Funct Genom, D-69120 Heidelberg, Germany

[12] Univ Hosp, Dept Pediat Immunol Hematol & Oncol, D-69120 Heidelberg, Germany

[13] Univ Oslo, Ctr Mol Med Norway, Nord European Mol Biol Lab Partnership, Forskningspk, N-0316 Oslo, Norway

[14] Oslo Univ Hosp, Inst Canc Genet & Informat, N-0316 Oslo, Norway

[15] Oslo Univ Hosp, Inst Canc Res, Dept Core Facil, N-0316 Oslo, Norway

[16] Natl Inst Environm Hlth Sci, Integrat Bioinformat Support Grp, Durham, NC 27709 USA

[17] Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Durham, NC 27709 USA

[18] Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany

[19] PROGETHER Prostate Canc Network, N-0316 Oslo, Norway

[20] Univ Med Ctr Hamburg Eppendorf, Martini Clin Prostate Canc Ctr, Martinistr 52, D-20246 Hamburg, Germany

[21] UT Southwestern Med Ctr, Dept Urol, Dallas, TX 75390 USA

[22] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada

[23] Natl Ctr Tumor Dis, NCT Trial Ctr, D-69120 Heidelberg, Germany

[24] German Canc Res Ctr, D-69120 Heidelberg, Germany

[25] German Canc Res Ctr, Bioinformat & Omics Data Analyt B240, D-69120 Heidelberg, Germany

[26] Univ Manchester, Manchester Canc Res Ctr, 555 Wilmslow Rd, Manchester, Lancs, England

[27] Ontario Inst Canc Res, Toronto, ON, Canada

[28] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada

[29] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany

[30] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany

[31] Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany

来源：

CANCER CELL | 2018年 / 34卷 / 06期

关键词：

ANDROGEN RECEPTOR; DNA METHYLATION; GENE-EXPRESSION; MUTATIONAL PROCESSES; CELL; TRANSCRIPTION; GENOME; HETEROGENEITY; PROGRESSION; SIGNATURE;

D O I：

10.1016/j.ccell.2018.10.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Identifying the earliest somatic changes in prostate cancer can give important insights into tumor evolution and aids in stratifying high- from low-risk disease. We integrated whole genome, transcriptome and methylome analysis of early-onset prostate cancers (diagnosis <= 55 years). Characterization across 292 prostate cancer genomes revealed age-related genomic alterations and a clock-like enzymatic-driven mutational process contributing to the earliest mutations in prostate cancer patients. Our integrative analysis identified four molecular subgroups, including a particularly aggressive subgroup with recurrent duplications associated with increased expression of ESRP1, which we validate in 12,000 tissue microarray tumors. Finally, we combined the patterns of molecular co-occurrence and risk-based subgroup information to deconvolve the molecular and clinical trajectories of prostate cancer from single patient samples.

引用

页码：996 / +

页数：24

共 50 条

[21] Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
Alshaker, Heba
Sacco, Keith
Alfraidi, Albandri
Muhammad, Aun
Winkler, Mathias
Pchejetski, Dmitri
ONCOTARGET, 2015, 6 (34) : 35556 - 35563
[22] Molecular correlates of intermediate- and high-risk localized prostate cancer
Ye, Huihui
Sowalsky, Adam G.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
[23] Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer
Bala, Pratyusha
Singh, Anurag Kumar
Kavadipula, Padmavathi
Kotapalli, Viswakalyan
Sabarinathan, Radhakrishnan
Bashyam, Murali Dharan
ONCOGENE, 2021, 40 (04) : 863 - 874
[24] Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
Montironi, Rodolfo
Cimadamore, Alessia
Lopez-Beltran, Antonio
Scarpelli, Marina
Aurilio, Gaetano
Santoni, Matteo
Massari, Francesco
Cheng, Liang
CELLS, 2020, 9 (05)
[25] The molecular biology of prostate cancer: current understanding and clinical implications
Gandhi, Jason
Afridi, Adil
Vatsia, Sohrab
Joshi, Gargi
Joshi, Gunjan
Kaplan, Steven A.
Smith, Noel L.
Khan, Sardar Ali
PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (01) : 22 - 36
[26] Molecular landscape of prostate cancer: Implications for current clinical trials
Khemlina, Galina
Ikeda, Sadakatsu
Kurzrock, Razelle
CANCER TREATMENT REVIEWS, 2015, 41 (09) : 761 - 766
[27] A Search for Reliable Molecular Markers of Prognosis in Prostate Cancer A Study of 240 Cases
Tradonsky, Alison
Rubin, Tammy
Beck, Rodney
Ring, Brian
Seitz, Robert
Mair, Sharon
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 918 - 930
[28] Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer
Lothion-Roy, Jennifer
Haigh, Daisy B.
Harris, Anna E.
Metzler, Veronika M.
Alsaleem, Mansour
Toss, Michael S.
Kariri, Yousif
Ntekim, Atara
Robinson, Brian D.
Khani, Francesca
Gudas, Lorraine J.
Allegrucci, Cinzia
James, Victoria H.
Madhusudan, Srinivasan
Mather, Melissa
Emes, Richard D.
Archer, Nathan
Fray, Rupert G.
Rakha, Emad
Jeyapalan, Jennie N.
Rutland, Catrin S.
Mongan, Nigel P.
Woodcock, Corinne L.
FRONTIERS IN GENETICS, 2023, 13
[29] A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome
Stylianou, Nataly
Lehman, Melanie L.
Wang, Chenwei
Fard, Atefeh Taherian
Rockstroh, Anja
Fazli, Ladan
Jovanovic, Lidija
Ward, Micheal
Sadowski, Martin C.
Kashyap, Abhishek S.
Buttyan, Ralph
Gleave, Martin E.
Westbrook, Thomas F.
Williams, Elizabeth D.
Gunter, Jennifer H.
Nelson, Colleen C.
Hollier, Brett G.
ONCOGENE, 2019, 38 (07) : 913 - 934
[30] Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
Cano, Amanda
Esteban-de-Antonio, Ester
Bernuz, Mireia
Puerta, Raquel
Garcia-Gonzalez, Pablo
de Rojas, Itziar
Olive, Claudia
Perez-Cordon, Alba
Montrreal, Laura
Nunez-Llaves, Raul
Sotolongo-Grau, Oscar
Alarcon-Martin, Emilio
Valero, Sergi
Alegret, Montserrat
Martin, Elvira
Martino-Adami, Pamela V.
Ettcheto, Miren
Camins, Antonio
Vivas, Assumpta
Gomez-Chiari, Marta
Tejero, Miguel angel
Orellana, Adelina
Tarraga, Lluis
Marquie, Marta
Ramirez, Alfredo
Marti, Merce
Pividori, Maria Isabel
Boada, Merce
Ruiz, Agustin
JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)

← 1 2 3 4 5 →